Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis. Oh J, O'Connor PW CNS Drugs. 2013 Jun 26. PMID: 23801528. Abstract CommentRecommendBookmarkWatch